Literature DB >> 3037011

The predicted primary structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus.

D Rasschaert, H Laude.   

Abstract

The complete nucleotide sequence of cloned cDNAs containing the E2 glycoprotein-encoding region of the genome of transmissible gastroenteritis virus (TGEV) has been determined. A single large translatable frame of 4.3 kb starting at 8.2 kb from the 3' end of the genome was identified. Its deduced amino acid sequence contains the characteristic features of a coronavirus peplomer protein: the precursor polypeptide of TGEV E2 is 1447 residues long (i.e. 285 longer than the avian infectious bronchitis coronavirus spike protein); partial N-terminal sequencing demonstrated that a putative secretory signal sequence of 16 amino acids is absent in the virion-associated protein; the predicted mol. wt. of the apoprotein is 158K; most of the 32 potential N-glycosylation sites available in the sequence are presumed to be functional to account for the difference between this and the experimentally determined value (200K to 220K); a typical hydrophobic sequence near the C terminus is likely to be responsible for anchoring the peplomer to the virion envelope.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037011     DOI: 10.1099/0022-1317-68-7-1883

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  51 in total

1.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies.

Authors:  E Routledge; R Stauber; M Pfleiderer; S G Siddell
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons.

Authors:  P B Sethna; S L Hung; D A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

5.  Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.

Authors:  C M Sánchez; A Izeta; J M Sánchez-Morgado; S Alonso; I Sola; M Balasch; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Sequence comparison of porcine respiratory coronavirus isolates reveals heterogeneity in the S, 3, and 3-1 genes.

Authors:  E M Vaughn; P G Halbur; P S Paul
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement.

Authors:  W V Corapi; R J Darteil; J C Audonnet; G E Chappuis
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Differentiation of transmissible gastroenteritis virus from porcine respiratory coronavirus and other antigenically related coronaviruses by using cDNA probes specific for the 5' region of the S glycoprotein gene.

Authors:  I Bae; D J Jackwood; D A Benfield; L J Saif; R D Wesley; H Hill
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

9.  Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus.

Authors:  M De Diego; M D Laviada; L Enjuanes; J M Escribano
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.